VOL. 125 | NO. 235 | Friday, December 3, 2010
VeinViewer Evaluated in Peer-Reviewed Journal
By Aisling Maki
The findings of the first peer review of a vein-viewing device manufactured by Memphis-based Christie Medical Holdings Inc. reports the device improves vascular success and is well-received by patients and staff.
The VeinViewer imaging system, which first became available in 2006, uses non-invasive infrared light to project a map of the patient’s veins on the surface of his skin.
“What you’re seeing is a real-time re-projection of the hidden veins that the device sees, and your skin is the movie screen. It’s completely contactless, so there’s no risk of cross-contamination, no heat issues, no radiation issues, and the device uses no lasers,” said Chris Schnee, general manager of Christie Medical Holdings.
The peer evaluation was performed by staff nurses on a pediatric surgical unit, according to the article by Holly Hess in the October/November issue of Pediatric Nursing.
The findings showed that the VeinViewer significantly improved first-attempt success rates in terms of locating a patient’s veins. It decreased both the number of attempts and the procedure time.
“From a clinical evidence perspective, you see a significant reduction in the number of needle-stick attempts to gain access and a significant increase in the ability for the caregiver to get the vein on the first try,” said Schnee.
This makes administering an IV much easier for the nurse and more comfortable for the patient.
Schnee said it’s no surprise to him that when departments with VeinViewer compare their patient satisfaction scores to those without the device, they show double or triple the positive patient satisfaction rankings.
In addition to its effectiveness, Schnee said the VeinViewer pays for itself.
“Also in that article, they go further to estimate the actual cost savings,” he said. “In our business-driven health care system, when you reduce the number of procedures, you reduce the time and you reduce the consumables.”
Schnee said peer-reviewed journals present the highest level of evidence that products do what they claim.
“They really demonstrate that the device can make a statistically significant difference to help health care, to help the patient and reduce cost,” he said.
Schnee said Christie Medical Holdings continues to improve the VeinViewer.
The second-generation device was launched in spring of 2008. The current third-generation Vein Viewer Vision is roughly 50 percent lighter, more powerful in its functioning modes and image quality, and significantly less costly than its predecessors.
“With all the raging debate about health care, the one thing we can be absolutely certain of in tomorrow’s health care system is that it will demand a product that improves the quality of health care, reduces the cost and has clinical evidence to prove that,” said Schnee.
Christie Medical Holdings Inc., formerly Luminetx Corp., is owned by Christie Digital Systems, a subsidiary of Japanese-based Ushio Inc.
Christie Digital Systems acquired Memphis-based Luminetx in late 2009.
“In the acquisition of Luminetx to become Christie Medical, the best is yet to come. We’re going to be constantly evolving not only the form factor of the device, but functionally what Vein Viewer can deliver as part of its capabilities,” said Schnee.
“We’ve added new staff members to our headcount and we’re planning on significant expansion in both staff and product capabilities and product availabilities. It’s going to be a really exciting 2011.”